Publications by authors named "F Perez-Errazquin"
Parkinson's disease (PD) is a chronic progressive and irreversible disease and the second most common neurodegenerative disease worldwide. In Spain, it affects around 120.000-150.
View Article and Find Full Text PDFArticle Synopsis
- The study conducted in Spain aimed to explore genetic factors related to Parkinson's Disease (PD) through the largest genome-wide association study focusing on a single country with diverse genetic backgrounds.
- Researchers analyzed data from 7,849 individuals to find specific genetic signals linked to PD risk and age at onset, discovering new associations particularly with the PARK2 gene and confirming others like SNCA and LRRK2.
- The findings suggest that Spain's unique genetic diversity can enhance understanding of complex diseases like PD, providing valuable insights for future genetic research.
Purpose: Studies concerning mortality in epilepsy have been performed primarily in Northern-Central Europe and US. The aim of this study was to provide information about mortality in people with epilepsy in Southern European countries.
Method: We studied a Spanish prevalence and incidence cohort of 2309 patients aged ≥14 years with epilepsy who were treated in an outpatient epilepsy clinic between 2000 and 2013.
Introduction: Informal caregivers of patients with Alzheimer's disease (AD) have a poor health-related quality of life (HRQOL). HRQOL is an increasingly common user-focused outcome measure. We have evaluated HRQOL longitudinally in caregivers of AD patients at baseline and at 12 months.
View Article and Find Full Text PDFIntroduction: Epilepsy is a chronic illness that requires a long-term periodic follow-up of the patient and this means that as time goes by the number of patients attended increases, with the ensuing added cost for the healthcare system.
Aim: To determine the factors involved in the time until an epileptic patient's next visit.
Patients And Methods: Our sample consisted of a selection of patients who visited the epilepsy clinic at our hospital consecutively during one year.